monophasic electrical stimuli Search Results


monophasic electrical stimuli  (AutoMate Scientific Inc)
96
AutoMate Scientific Inc monophasic electrical stimuli
Monophasic Electrical Stimuli, supplied by AutoMate Scientific Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monophasic+electrical+stimuli/pmc06165719-250-8-17?v=AutoMate+Scientific+Inc
Average 96 stars, based on 1 article reviews
monophasic electrical stimuli - by Bioz Stars, 2026-07
96/100 stars
  Buy from Supplier
electrical pulse stimulation  (Digitimer North America LLC)
97
Digitimer North America LLC electrical pulse stimulation
Fig. 1 Effects of chronic THC treatment on striatal DA release in acute brain slices using FSCV. A Schematic illustrating chronic treatment and timepoints of FSCV recordings in striatal subregions where a carbon fiber recording electrode and stimulating electrode were placed to record <t>electrical</t> <t>stimulation-elicited</t> DA release. Purple rectangles indicate abstinence timepoints used in recordings. B DA release in males (♂) during early abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,72) = 0.02, p = 0.8712), DMS (Ftreatment(1,84) = 1.01, p = 0.3168), or NAc (Ftreatment(1,84) = 3.07, p = 0.0834). C DA release in males during late abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,186) = 0.45, p = 0.5019) or NAc (Ftreatment(1,87) = 0.64, p = 0.4270). In DMS THC treated mice had elevated DA release (Ftreatment (1,71) = 13.56; p = 0.0004). D DA release in females (♀) during early abstinence following chronic treatment. DA release was elevated in DLS (Ftreatment(1,72) = 51.61, p = <0.0001), DMS (Ftreatment(1,72) = 33.82, p = <0.0001) and NAc (Ftreatment(1,60) = 11.69, p = 0.0011). E DA release in females during late abstinence following acute treatment. No differences detected in DLS (Ftreatment(1,84) = 2.54, p = 0.1151), DMS (Ftreatment(1,84) = 1.68, p = 0.1981), or NAc (Ftreatment(1,72) = <0.01, p = 0.9976).
Electrical Pulse Stimulation, supplied by Digitimer North America LLC, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monophasic+electrical+stimuli/pm35478010-81-6-25?v=Digitimer+North+America+LLC
Average 97 stars, based on 1 article reviews
electrical pulse stimulation - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier
ds7  (Digitimer Ltd)
90
Digitimer Ltd ds7
Fig. 1 Effects of chronic THC treatment on striatal DA release in acute brain slices using FSCV. A Schematic illustrating chronic treatment and timepoints of FSCV recordings in striatal subregions where a carbon fiber recording electrode and stimulating electrode were placed to record <t>electrical</t> <t>stimulation-elicited</t> DA release. Purple rectangles indicate abstinence timepoints used in recordings. B DA release in males (♂) during early abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,72) = 0.02, p = 0.8712), DMS (Ftreatment(1,84) = 1.01, p = 0.3168), or NAc (Ftreatment(1,84) = 3.07, p = 0.0834). C DA release in males during late abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,186) = 0.45, p = 0.5019) or NAc (Ftreatment(1,87) = 0.64, p = 0.4270). In DMS THC treated mice had elevated DA release (Ftreatment (1,71) = 13.56; p = 0.0004). D DA release in females (♀) during early abstinence following chronic treatment. DA release was elevated in DLS (Ftreatment(1,72) = 51.61, p = <0.0001), DMS (Ftreatment(1,72) = 33.82, p = <0.0001) and NAc (Ftreatment(1,60) = 11.69, p = 0.0011). E DA release in females during late abstinence following acute treatment. No differences detected in DLS (Ftreatment(1,84) = 2.54, p = 0.1151), DMS (Ftreatment(1,84) = 1.68, p = 0.1981), or NAc (Ftreatment(1,72) = <0.01, p = 0.9976).
Ds7, supplied by Digitimer Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monophasic+electrical+stimuli/pm30024337-42-11-13?v=Digitimer+Ltd
Average 90 stars, based on 1 article reviews
ds7 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
electrical pulse stimulation  (AutoMate Scientific Inc)
97
AutoMate Scientific Inc electrical pulse stimulation
Fig. 1 Effects of chronic THC treatment on striatal DA release in acute brain slices using FSCV. A Schematic illustrating chronic treatment and timepoints of FSCV recordings in striatal subregions where a carbon fiber recording electrode and stimulating electrode were placed to record <t>electrical</t> <t>stimulation-elicited</t> DA release. Purple rectangles indicate abstinence timepoints used in recordings. B DA release in males (♂) during early abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,72) = 0.02, p = 0.8712), DMS (Ftreatment(1,84) = 1.01, p = 0.3168), or NAc (Ftreatment(1,84) = 3.07, p = 0.0834). C DA release in males during late abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,186) = 0.45, p = 0.5019) or NAc (Ftreatment(1,87) = 0.64, p = 0.4270). In DMS THC treated mice had elevated DA release (Ftreatment (1,71) = 13.56; p = 0.0004). D DA release in females (♀) during early abstinence following chronic treatment. DA release was elevated in DLS (Ftreatment(1,72) = 51.61, p = <0.0001), DMS (Ftreatment(1,72) = 33.82, p = <0.0001) and NAc (Ftreatment(1,60) = 11.69, p = 0.0011). E DA release in females during late abstinence following acute treatment. No differences detected in DLS (Ftreatment(1,84) = 2.54, p = 0.1151), DMS (Ftreatment(1,84) = 1.68, p = 0.1981), or NAc (Ftreatment(1,72) = <0.01, p = 0.9976).
Electrical Pulse Stimulation, supplied by AutoMate Scientific Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monophasic+electrical+stimuli/bio_rxiv__2022__04__12__488031-191-6-25?v=AutoMate+Scientific+Inc
Average 97 stars, based on 1 article reviews
electrical pulse stimulation - by Bioz Stars, 2026-07
97/100 stars
  Buy from Supplier
zoll 1600 monophasic defibrillator  (ZOLL Medical)
90
ZOLL Medical zoll 1600 monophasic defibrillator
Fig. 1 Effects of chronic THC treatment on striatal DA release in acute brain slices using FSCV. A Schematic illustrating chronic treatment and timepoints of FSCV recordings in striatal subregions where a carbon fiber recording electrode and stimulating electrode were placed to record <t>electrical</t> <t>stimulation-elicited</t> DA release. Purple rectangles indicate abstinence timepoints used in recordings. B DA release in males (♂) during early abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,72) = 0.02, p = 0.8712), DMS (Ftreatment(1,84) = 1.01, p = 0.3168), or NAc (Ftreatment(1,84) = 3.07, p = 0.0834). C DA release in males during late abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,186) = 0.45, p = 0.5019) or NAc (Ftreatment(1,87) = 0.64, p = 0.4270). In DMS THC treated mice had elevated DA release (Ftreatment (1,71) = 13.56; p = 0.0004). D DA release in females (♀) during early abstinence following chronic treatment. DA release was elevated in DLS (Ftreatment(1,72) = 51.61, p = <0.0001), DMS (Ftreatment(1,72) = 33.82, p = <0.0001) and NAc (Ftreatment(1,60) = 11.69, p = 0.0011). E DA release in females during late abstinence following acute treatment. No differences detected in DLS (Ftreatment(1,84) = 2.54, p = 0.1151), DMS (Ftreatment(1,84) = 1.68, p = 0.1981), or NAc (Ftreatment(1,72) = <0.01, p = 0.9976).
Zoll 1600 Monophasic Defibrillator, supplied by ZOLL Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monophasic+electrical+stimuli/10__1161_slash_circoutcomes__116__003577-69-10-14?v=ZOLL+Medical
Average 90 stars, based on 1 article reviews
zoll 1600 monophasic defibrillator - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
osiris neurostimulator  (INOMED Inc)
90
INOMED Inc osiris neurostimulator
Fig. 1 Effects of chronic THC treatment on striatal DA release in acute brain slices using FSCV. A Schematic illustrating chronic treatment and timepoints of FSCV recordings in striatal subregions where a carbon fiber recording electrode and stimulating electrode were placed to record <t>electrical</t> <t>stimulation-elicited</t> DA release. Purple rectangles indicate abstinence timepoints used in recordings. B DA release in males (♂) during early abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,72) = 0.02, p = 0.8712), DMS (Ftreatment(1,84) = 1.01, p = 0.3168), or NAc (Ftreatment(1,84) = 3.07, p = 0.0834). C DA release in males during late abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,186) = 0.45, p = 0.5019) or NAc (Ftreatment(1,87) = 0.64, p = 0.4270). In DMS THC treated mice had elevated DA release (Ftreatment (1,71) = 13.56; p = 0.0004). D DA release in females (♀) during early abstinence following chronic treatment. DA release was elevated in DLS (Ftreatment(1,72) = 51.61, p = <0.0001), DMS (Ftreatment(1,72) = 33.82, p = <0.0001) and NAc (Ftreatment(1,60) = 11.69, p = 0.0011). E DA release in females during late abstinence following acute treatment. No differences detected in DLS (Ftreatment(1,84) = 2.54, p = 0.1151), DMS (Ftreatment(1,84) = 1.68, p = 0.1981), or NAc (Ftreatment(1,72) = <0.01, p = 0.9976).
Osiris Neurostimulator, supplied by INOMED Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monophasic+electrical+stimuli/pm26129769-62-6-22?v=INOMED+Inc
Average 90 stars, based on 1 article reviews
osiris neurostimulator - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
275 axial gradiometers  (VSM MedTech Ltd)
90
VSM MedTech Ltd 275 axial gradiometers
Fig. 1 Effects of chronic THC treatment on striatal DA release in acute brain slices using FSCV. A Schematic illustrating chronic treatment and timepoints of FSCV recordings in striatal subregions where a carbon fiber recording electrode and stimulating electrode were placed to record <t>electrical</t> <t>stimulation-elicited</t> DA release. Purple rectangles indicate abstinence timepoints used in recordings. B DA release in males (♂) during early abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,72) = 0.02, p = 0.8712), DMS (Ftreatment(1,84) = 1.01, p = 0.3168), or NAc (Ftreatment(1,84) = 3.07, p = 0.0834). C DA release in males during late abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,186) = 0.45, p = 0.5019) or NAc (Ftreatment(1,87) = 0.64, p = 0.4270). In DMS THC treated mice had elevated DA release (Ftreatment (1,71) = 13.56; p = 0.0004). D DA release in females (♀) during early abstinence following chronic treatment. DA release was elevated in DLS (Ftreatment(1,72) = 51.61, p = <0.0001), DMS (Ftreatment(1,72) = 33.82, p = <0.0001) and NAc (Ftreatment(1,60) = 11.69, p = 0.0011). E DA release in females during late abstinence following acute treatment. No differences detected in DLS (Ftreatment(1,84) = 2.54, p = 0.1151), DMS (Ftreatment(1,84) = 1.68, p = 0.1981), or NAc (Ftreatment(1,72) = <0.01, p = 0.9976).
275 Axial Gradiometers, supplied by VSM MedTech Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monophasic+electrical+stimuli/pmc11323619-102-19-5?v=VSM+MedTech+Ltd
Average 90 stars, based on 1 article reviews
275 axial gradiometers - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
direct current (dc) type 360-j monophasic defibrillator  (Nihon Kohden corporation)
90
Nihon Kohden corporation direct current (dc) type 360-j monophasic defibrillator
Fig. 1 Effects of chronic THC treatment on striatal DA release in acute brain slices using FSCV. A Schematic illustrating chronic treatment and timepoints of FSCV recordings in striatal subregions where a carbon fiber recording electrode and stimulating electrode were placed to record <t>electrical</t> <t>stimulation-elicited</t> DA release. Purple rectangles indicate abstinence timepoints used in recordings. B DA release in males (♂) during early abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,72) = 0.02, p = 0.8712), DMS (Ftreatment(1,84) = 1.01, p = 0.3168), or NAc (Ftreatment(1,84) = 3.07, p = 0.0834). C DA release in males during late abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,186) = 0.45, p = 0.5019) or NAc (Ftreatment(1,87) = 0.64, p = 0.4270). In DMS THC treated mice had elevated DA release (Ftreatment (1,71) = 13.56; p = 0.0004). D DA release in females (♀) during early abstinence following chronic treatment. DA release was elevated in DLS (Ftreatment(1,72) = 51.61, p = <0.0001), DMS (Ftreatment(1,72) = 33.82, p = <0.0001) and NAc (Ftreatment(1,60) = 11.69, p = 0.0011). E DA release in females during late abstinence following acute treatment. No differences detected in DLS (Ftreatment(1,84) = 2.54, p = 0.1151), DMS (Ftreatment(1,84) = 1.68, p = 0.1981), or NAc (Ftreatment(1,72) = <0.01, p = 0.9976).
Direct Current (Dc) Type 360 J Monophasic Defibrillator, supplied by Nihon Kohden corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monophasic+electrical+stimuli/pmc04020898-34-9-15?v=Nihon+Kohden+corporation
Average 90 stars, based on 1 article reviews
direct current (dc) type 360-j monophasic defibrillator - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
c-tens sm 1 ce 0197  (Pierenkemper GMBH)
90
Pierenkemper GMBH c-tens sm 1 ce 0197
Comparison of differences for c-PN during trunk flexion v . Abbreviations: c-PN, cervicotonic provocation nystagmus; c-TENS, cervical <t>monophasic</t> <t>transcutaneous</t> <t>electrical</t> nerve <t>stimulation.</t>
C Tens Sm 1 Ce 0197, supplied by Pierenkemper GMBH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monophasic+electrical+stimuli/pmc05205534-82-5-16?v=Pierenkemper+GMBH
Average 90 stars, based on 1 article reviews
c-tens sm 1 ce 0197 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
magnetic stimulator  (Magstim Company)
90
Magstim Company magnetic stimulator
Comparison of differences for c-PN during trunk flexion v . Abbreviations: c-PN, cervicotonic provocation nystagmus; c-TENS, cervical <t>monophasic</t> <t>transcutaneous</t> <t>electrical</t> nerve <t>stimulation.</t>
Magnetic Stimulator, supplied by Magstim Company, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monophasic+electrical+stimuli/pm15905126-134-33-34?v=Magstim+Company
Average 90 stars, based on 1 article reviews
magnetic stimulator - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
m-series monophasic defibrillators  (ZOLL Medical)
90
ZOLL Medical m-series monophasic defibrillators
Comparison of differences for c-PN during trunk flexion v . Abbreviations: c-PN, cervicotonic provocation nystagmus; c-TENS, cervical <t>monophasic</t> <t>transcutaneous</t> <t>electrical</t> nerve <t>stimulation.</t>
M Series Monophasic Defibrillators, supplied by ZOLL Medical, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/monophasic+electrical+stimuli/pm16264081-55-5-11?v=ZOLL+Medical
Average 90 stars, based on 1 article reviews
m-series monophasic defibrillators - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 1 Effects of chronic THC treatment on striatal DA release in acute brain slices using FSCV. A Schematic illustrating chronic treatment and timepoints of FSCV recordings in striatal subregions where a carbon fiber recording electrode and stimulating electrode were placed to record electrical stimulation-elicited DA release. Purple rectangles indicate abstinence timepoints used in recordings. B DA release in males (♂) during early abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,72) = 0.02, p = 0.8712), DMS (Ftreatment(1,84) = 1.01, p = 0.3168), or NAc (Ftreatment(1,84) = 3.07, p = 0.0834). C DA release in males during late abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,186) = 0.45, p = 0.5019) or NAc (Ftreatment(1,87) = 0.64, p = 0.4270). In DMS THC treated mice had elevated DA release (Ftreatment (1,71) = 13.56; p = 0.0004). D DA release in females (♀) during early abstinence following chronic treatment. DA release was elevated in DLS (Ftreatment(1,72) = 51.61, p = <0.0001), DMS (Ftreatment(1,72) = 33.82, p = <0.0001) and NAc (Ftreatment(1,60) = 11.69, p = 0.0011). E DA release in females during late abstinence following acute treatment. No differences detected in DLS (Ftreatment(1,84) = 2.54, p = 0.1151), DMS (Ftreatment(1,84) = 1.68, p = 0.1981), or NAc (Ftreatment(1,72) = <0.01, p = 0.9976).

Journal: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Article Title: Changes in striatal dopamine release, sleep, and behavior during spontaneous Δ-9-tetrahydrocannabinol abstinence in male and female mice.

doi: 10.1038/s41386-022-01326-0

Figure Lengend Snippet: Fig. 1 Effects of chronic THC treatment on striatal DA release in acute brain slices using FSCV. A Schematic illustrating chronic treatment and timepoints of FSCV recordings in striatal subregions where a carbon fiber recording electrode and stimulating electrode were placed to record electrical stimulation-elicited DA release. Purple rectangles indicate abstinence timepoints used in recordings. B DA release in males (♂) during early abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,72) = 0.02, p = 0.8712), DMS (Ftreatment(1,84) = 1.01, p = 0.3168), or NAc (Ftreatment(1,84) = 3.07, p = 0.0834). C DA release in males during late abstinence following chronic treatment. No differences detected in DLS (Ftreatment(1,186) = 0.45, p = 0.5019) or NAc (Ftreatment(1,87) = 0.64, p = 0.4270). In DMS THC treated mice had elevated DA release (Ftreatment (1,71) = 13.56; p = 0.0004). D DA release in females (♀) during early abstinence following chronic treatment. DA release was elevated in DLS (Ftreatment(1,72) = 51.61, p = <0.0001), DMS (Ftreatment(1,72) = 33.82, p = <0.0001) and NAc (Ftreatment(1,60) = 11.69, p = 0.0011). E DA release in females during late abstinence following acute treatment. No differences detected in DLS (Ftreatment(1,84) = 2.54, p = 0.1151), DMS (Ftreatment(1,84) = 1.68, p = 0.1981), or NAc (Ftreatment(1,72) = <0.01, p = 0.9976).

Article Snippet: DA release was evoked by rectangular, electrical pulse stimulation (250–800 μA; 2 ms, monophasic) applied every 5min with a NL 800 A Current Stimulus Isolator (Digitimer, Hertfordshire, UK).

Techniques:

Comparison of differences for c-PN during trunk flexion v . Abbreviations: c-PN, cervicotonic provocation nystagmus; c-TENS, cervical monophasic transcutaneous electrical nerve stimulation.

Journal: International Archives of Otorhinolaryngology

Article Title: Tonic Investigation Concept of Cervico-vestibular Muscle Afferents

doi: 10.1055/s-0036-1583759

Figure Lengend Snippet: Comparison of differences for c-PN during trunk flexion v . Abbreviations: c-PN, cervicotonic provocation nystagmus; c-TENS, cervical monophasic transcutaneous electrical nerve stimulation.

Article Snippet: We prospectively investigated whether placebo-controlled monophasic cervical transcutaneous electrical nerve stimulation (c-TENS, SM 1, CE 0197, Pierenkemper GMBH) would influence the c-PN.

Techniques: Comparison